Evaluating the Prognostic Capability of ctDNA as a Biomarker in Pancreatic Cancer Patients Undergoing Neoadjuvant Chemotherapy
Clinical trial NCT04616131 · RECRUITING
Trial details
- NCT number
- NCT04616131
- Sponsor
- Northwestern University
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2020-10-01
- Primary completion
- 2027-10-01
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.